Stock Research for ACET


Featured Broker: Ally Invest

Get the due diligence for another stock.


ACET Stock Chart & Research Data

The ACET chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ACET chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


ACET Due diligence Resources & Stock Charts

The ACET stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ACET Detailed Price Forecast - CNN Money CNN View ACET Detailed Summary - Google Finance
Yahoo View ACET Detailed Summary - Yahoo! Finance Zacks View ACET Stock Research & Analysis -

Stock Analysis

TradeIdeas View ACET Trends & Analysis - Trade-Ideas Barrons View ACET Major Holders - Barrons
NASDAQ View ACET Call Transcripts - NASDAQ Seeking View ACET Breaking News & Analysis - Seeking Alpha
Spotlight View ACET Annual Report - OTC Report View ACET OTC Short Report -
TradeKing View ACET Fundamentals - TradeKing Charts View ACET SEC Filings - Bar Chart
WSJ View Historical Prices for ACET - The WSJ Morningstar View Performance/Total Return for ACET - Morningstar
MarketWatch View the Analyst Estimates for ACET - MarketWatch CNBC View the Earnings History for ACET - CNBC
StockMarketWatch View the ACET Earnings - StockMarketWatch MacroAxis View ACET Buy or Sell Recommendations - MacroAxis
Bullish View the ACET Bullish Patterns - American Bulls Short Pains View ACET Short Pain Metrics -

Social Media Mentions

StockTwits View ACET Stock Mentions - StockTwits PennyStocks View ACET Stock Mentions - PennyStockTweets
Twitter View ACET Stock Mentions - Twitter Invest Hub View ACET Investment Forum News - Investor Hub
Yahoo View ACET Stock Mentions - Yahoo! Message Board Seeking Alpha View ACET Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for ACET - Insider Cow View Insider Transactions for ACET - Insider Cow
CNBC View ACET Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ACET - OTC Markets
Yahoo View Insider Transactions for ACET - Yahoo! Finance NASDAQ View Institutional Holdings for ACET - NASDAQ

Stock Charts

FinViz View ACET Stock Insight & Charts - StockCharts View ACET Investment Charts -
BarChart View ACET Stock Overview & Charts - BarChart Trading View View ACET User Generated Charts - Trading View

Latest Financial News for ACET

6 Poorly Performing Stocks
Posted on Tuesday March 19, 2019

The return on equity of -211.13% and return on assets of -41.80% are underperforming 84% of companies in the Global Drug Manufacturers - Specialty and Generic industry. The company's largest guru shareholder is Jim Simons (Trades, Portfolio)' Renaissance Technologies with 4.75% of outstanding shares, followed by Chuck Royce (Trades, Portfolio) with 1.53%. The return on equity of -0.71% and return on assets of -0.42% are underperforming 72% of companies in the Global Coal industry.

[$$] Palm Restaurant Family Feud Moves to Bankruptcy Court
Posted on Monday March 11, 2019

The company that holds The Palm Restaurant’s trademarks filed for bankruptcy in a bid to reach a deal over disputed royalty payments among descendants of the 93-year-old steakhouse’s chain’s founders.

[$$] Generic Drug Distributor Aceto Finds Bidder for Subsidiary
Posted on Friday March 08, 2019

Corp., the generic drug distributor that filed for bankruptcy last month, has found a bidder for its subsidiary, Rising Pharmaceuticals Inc. Shore Suven Pharma Inc. has agreed to pay $15 million for Rising and its subsidiaries, Aceto said, subject to higher or better offers at auction.

ACETO Enters into “Stalking Horse” Agreement to Sell Rising Pharmaceuticals
Posted on Thursday March 07, 2019

ACETO Corporation (ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today that it has entered into a “stalking-horse” asset purchase agreement with Shore Suven Pharma, Inc. to sell the assets of Rising Pharmaceuticals and Rising’s subsidiaries for gross cash proceeds of $15 million, plus the assumption of operating liabilities and customer obligations related to the acquired business on a cash-free and debt-free basis. Shore Suven Pharma, Inc. is a joint venture between Suven Life Sciences Limited, an India-based provider of contract research and manufacturing services for the global life sciences industry, and Shore Pharma Investments, LLC, a company founded by Vimal Kavuru to acquire generic drug assets.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.